These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

514 related items for PubMed ID: 30528882

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. 3'3-Diindolylmethane inhibits migration, invasion and metastasis of hepatocellular carcinoma by suppressing FAK signaling.
    Li WX, Chen LP, Sun MY, Li JT, Liu HZ, Zhu W.
    Oncotarget; 2015 Sep 15; 6(27):23776-92. PubMed ID: 26068982
    [Abstract] [Full Text] [Related]

  • 3. Platycodin D induces apoptosis, and inhibits adhesion, migration and invasion in HepG2 hepatocellular carcinoma cells.
    Li T, Xu WS, Wu GS, Chen XP, Wang YT, Lu JJ.
    Asian Pac J Cancer Prev; 2014 Sep 15; 15(4):1745-9. PubMed ID: 24641402
    [Abstract] [Full Text] [Related]

  • 4. Notch1 downregulation combined with interleukin-24 inhibits invasion and migration of hepatocellular carcinoma cells.
    Han B, Liu SH, Guo WD, Zhang B, Wang JP, Cao YK, Liu J.
    World J Gastroenterol; 2015 Sep 07; 21(33):9727-35. PubMed ID: 26361419
    [Abstract] [Full Text] [Related]

  • 5. Akebia saponin E, as a novel PIKfyve inhibitor, induces lysosome-associated cytoplasmic vacuolation to inhibit proliferation of hepatocellular carcinoma cells.
    Peng P, Jia D, Cao L, Lu W, Liu X, Liang C, Pan Z, Fang Z.
    J Ethnopharmacol; 2021 Feb 10; 266():113446. PubMed ID: 33031902
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
    Wu WL, Wang WY, Yao WQ, Li GD.
    Int J Mol Med; 2015 Dec 10; 36(6):1713-9. PubMed ID: 26499886
    [Abstract] [Full Text] [Related]

  • 10. Extract of Stellerachamaejasme L(ESC) inhibits growth and metastasis of human hepatocellular carcinoma via regulating microRNA expression.
    Liu X, Wang S, Xu J, Kou B, Chen D, Wang Y, Zhu X.
    BMC Complement Altern Med; 2018 Mar 20; 18(1):99. PubMed ID: 29554896
    [Abstract] [Full Text] [Related]

  • 11. Chelerythrine Inhibits Human Hepatocellular Carcinoma Metastasis in Vitro.
    Zhu Y, Pan Y, Zhang G, Wu Y, Zhong W, Chu C, Qian Y, Zhu G.
    Biol Pharm Bull; 2018 Jan 01; 41(1):36-46. PubMed ID: 29093327
    [Abstract] [Full Text] [Related]

  • 12. Recombinant porcine NK-lysin inhibits the invasion of hepatocellular carcinoma cells in vitro.
    Khan A, Fan K, Sun N, Yin W, Sun Y, Sun P, Jahejo AR, Li H.
    Int J Biol Macromol; 2019 Nov 01; 140():1249-1259. PubMed ID: 31465800
    [Abstract] [Full Text] [Related]

  • 13. The anti-metastatic effect of 8-MOP on hepatocellular carcinoma is potentiated by the down-regulation of bHLH transcription factor DEC1.
    Xiong J, Yang H, Luo W, Shan E, Liu J, Zhang F, Xi T, Yang J.
    Pharmacol Res; 2016 Mar 01; 105():121-33. PubMed ID: 26808085
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The effects of MIBG on the invasive properties of HepG2 hepatocellular carcinoma cells.
    Su Y, Guan XQ, Liu FQ, Wang YL.
    Int J Mol Med; 2014 Sep 01; 34(3):842-8. PubMed ID: 24970008
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Downregulation of Notch1 inhibits the invasion of human hepatocellular carcinoma HepG2 and MHCC97H cells through the regulation of PTEN and FAK.
    Hu YJ, Li HY, Qiu KJ, Li DC, Zhou JH, Hu YH, Zhang FM.
    Int J Mol Med; 2014 Oct 01; 34(4):1081-6. PubMed ID: 25110169
    [Abstract] [Full Text] [Related]

  • 20. Shufeng Jiedu Capsule and its active ingredients induce apoptosis, inhibit migration and invasion, and enhances doxorubicin therapeutic efficacy in hepatocellular carcinoma.
    Xia J, Rong L, Sawakami T, Inagaki Y, Song P, Hasegawa K, Sakamoto Y, Tang W.
    Biomed Pharmacother; 2018 Mar 01; 99():921-930. PubMed ID: 29710492
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.